secwatch.observer — SEC 8-K summary
======================================

Issuer:     VYNE Therapeutics Inc. (VYNE)
CIK:        0001566044
Form:       8-K
Filed at:   2023-01-17T23:59:59+00:00
Accession:  0001104659-23-004316
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

VYNE redeems all Series A Preferred Stock for $360K, eliminates series designation
--------------------------------------------------------------------------------

- Redeemed all outstanding Series A Convertible Preferred Stock for $360,000 (120% of stated value) on Jan 17, 2023.
- Filed Certificate of Elimination removing designation of 3,000 Series A shares with Delaware Secretary of State.
- Eliminated shares resume status as authorized but unissued and non-designated preferred stock.
- No outstanding Series A shares remain after redemption; sole holder received full payment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1566044/000110465923004316/0001104659-23-004316-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1566044/000110465923004316/tm233612d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-004316

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer